OHSU
Return to Listing

1 result(s) for MK-3475

PI Name Protocol # Title
Jeremy Cetnar IRB00009512 A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900475) versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program